Proteins and Peptides

23 Apr 2008 Spectrum Pharmaceuticals Provides an Update on Ozarelix in BPH
22 Apr 2008 Agennix Initiates A Randomized Double-Blind, Placebo-Controlled Phase 2 Study of Oral Talactoferrin in Severe Sepsis
22 Apr 2008 Eurand Announces EUR-1008 (Zentase) Eligibility for European Centralized Review
21 Apr 2008 Savient Provides Update On Puricase(R) (pegloticase) Biologics License Application
21 Apr 2008 Nostrum Announces the Successful Completion of Early Proof-of-Concept Study for its Novel Clot Busting Therapeutic Protein
21 Apr 2008 Genzyme Provides Update on Myozyme(R) Manufacturing
19 Apr 2008 Aida Announces New Anti-Cancer Drug Under Development
18 Apr 2008 Lipid Sciences Presents HDL Mimetic Peptide Data at Arteriosclerosis, Thrombosis, and Vascular Biology Annual Conference
17 Apr 2008 12 Month Analysis of Juvista Clinical Trials 0050 and 0036
16 Apr 2008 Zelos Therapeutics and Aegis Therapeutics Announce Collaboration for Intranasal Delivery of Zelos’ ZT-031
16 Apr 2008 Teva Seeks Approval for the Extension of its Indication to Include the Treatment of Patients with a First Clinical Event Suggestive of MS
14 Apr 2008 Nuvelo Announces Preclinical Data for NU206 Demonstrating Potent Therapeutic Activity in Oral Mucositis Models
14 Apr 2008 TransMolecular Unveils First Data on TM601 Anti-Angiogenic Mechanismof-Action at AACR Annual Meeting
14 Apr 2008 Debiopharm and Airmid Sign Option and License Agreement
10 Apr 2008 Copaxone® Significantly Reduced Annual Relapse Rates And Stabilized Disease Progression In Relapsing Remitting Multiple Sclerosis Patients Failing Interferon Treatment
09 Apr 2008 Pfizer Statement on Exubera Labeling Update in the United States
09 Apr 2008 ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II StudyEvaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke
09 Apr 2008 Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
09 Apr 2008 Acorda Therapeutics Signs GGF2 Manufacturing Agreement with CMC ICOS
08 Apr 2008 Protox Initiates Phase 2 BPH Study
08 Apr 2008 WEX Starts Phase III Trial of Tectin(TM) for Cancer Pain
04 Apr 2008 FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis
03 Apr 2008 Kamada Announces that it had Succesfully Met the Primary Endpoint in its US Phase III Clinical Trial with Intravenous AAT
02 Apr 2008 Radius Completes Enrollment of Phase II Clinical Trial of BA058 for Osteoporosis
01 Apr 2008 ThromboGenics Completes Patient Enrolment in the Phase IIb Trial of

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top